Related Experiment Video
Updated: Jan 16, 2026

08:25
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
4.0K
Kinetic Model with Feedback Cycle for Age-Dependent Amyloid Beta Accumulation in Mice
Vivian Tyng1, Michael E Kellman1,2,3
1Department of Chemistry and Biochemistry, University of Oregon, Eugene, OR 97403, USA.
International Journal of Molecular Sciences
|September 27, 2025
Summary
This study models amyloid beta (Aβ) buildup in Alzheimer's disease (AD) using a kinetic approach. Computational results suggest combination therapies may help, but caution is advised as synergy isn't guaranteed.
Area of Science:
- Neuroscience
- Biochemistry
- Computational Biology
Background:
- Alzheimer's disease (AD) pathogenesis involves amyloid beta (Aβ) accumulation.
- Aβ is implicated in complex feedback loops contributing to neurodegeneration.
- The exact mechanisms driving Aβ buildup and AD progression remain incompletely understood.
Purpose of the Study:
- To develop a quantitative kinetic model of Aβ buildup in a mouse model (Tg2576).
- To explore the potential efficacy of various therapeutic strategies for mitigating Aβ accumulation.
- To investigate the role of positive feedback loops in Aβ pathogenesis.
Main Methods:
- Developed a simple kinetic model simulating coupled feedback cycles of Aβ buildup.
- Utilized literature data from Tg2576 mice for model parameterization.
- Performed computational simulations to test hypothetical therapeutic interventions.
Main Results:
- The kinetic model successfully captured Aβ buildup dynamics.
- Simulations indicated potential benefits from combination therapeutic approaches.
- No clear synergistic effects were consistently observed, suggesting complexity in intervention efficacy.
Conclusions:
- Positive feedback cycles are crucial in Aβ buildup and AD pathogenesis.
- Kinetic modeling provides a quantitative framework for understanding AD complexity.
- Therapeutic strategies targeting Aβ may require careful consideration of feedback mechanisms to optimize efficacy.
Keywords:
Alzheimer’s diseaseamyloid betacombination interventionskinetic modelingpositive feedbackvicious cycle
